Zhao and colleagues (73) studied serum fibroblast growth factor 23 (FGF23) in healthy women or pregnant women with preeclampsia and examined its role mediating placental angiogenesis through ERK1/2-EGR1 signaling. This evidence concerns the gene MAPK3 and preeclampsia.